Aptamers
Group leader
Víctor Manuel González Muñoz
victor.m.gonzalez(ELIMINAR)@hrc.es
Tlf.: +34 91 336 81 73
Principal Investigator
- Manuel Soto Álvarez
- María Elena Martín Palma
Collaborating Staff
- María Isabel Pérez Morgado
- Silvia Sacristán López
- María del Val Toledo Lobo
- Juan Manuel Gómez Hernández
- Marta García Hernández
- Raquel Ferreras Martín
- Ignacio Iturrieta Zuazo
- Mariana Fuentes-Quintana Miralles
- Laura Herraiz Benitez
- Ana María Salgado Figueroa
- Manuel Pascual Mellado
Principal Investigator
- Manuel Soto Álvarez
- María Elena Martín Palma
Collaborating Staff
- María Isabel Pérez Morgado
- Silvia Sacristán López
- María del Val Toledo Lobo
- Juan Manuel Gómez Hernández
- Marta García Hernández
- Raquel Ferreras Martín
- Ignacio Iturrieta Zuazo
- Mariana Fuentes-Quintana Miralles
- Laura Herraiz Benitez
- Ana María Salgado Figueroa
- Manuel Pascual Mellado
STRATEGIC OBJECTIVES
- Development of detection systems based on aptamer technology that aim to improve the diagnosis and/or prognosis of different pathologies. Thus, enabling better patient care and cost savings for the health system.
- Development of aptamers against targets involved in different pathologies (cancer, infections, etc.) for use in the design of drugs that will translate to new therapeutic options for patients.
- Identification of new therapeutic targets in cancer.
RESEARCH LINES
- Development of aptamers with a therapeutic potential.
- Development of aptamer-based diagnostic systems.
- Involvement of kinase Mnk1b in tumourigenesis
Location
Aptamers Laboratory
Ramón y Cajal University Hospital
1st floor right
+34 91 336 83 88
Keywords
aptamer, diagnosis, MNK, therapy